The latest from Biosyn Pharmaceuticals — company milestones, product news, and updates from our journey to make quality healthcare accessible.
With Calmare, Calmare Plus, and Panmist Gel, Biosyn enters the ENT market with a complete nasal-care suite — covering daily hygiene, active relief, and sustained moisturization.
Read moreOur R&D pipeline spans pediatric and ENT care, with several compounds approaching registration and launch readiness.
Read moreAll marketed Biosyn products are now notified with the Egyptian Drug Authority, reinforcing our commitment to quality and compliance.
Read moreMore updates coming soon as Biosyn continues to grow.
Cycle meetings, training sessions, conferences, new team members, and partnership announcements — a running log of our journey.
Our team joined industry peers to share insights on accessible, quality healthcare and connect with partners across the sector.
We're strengthening our leadership as we grow — welcoming experienced talent to help drive our mission forward.
Continuous learning is part of our culture — our team regularly invests in development to stay at the forefront of the field.
Our teams aligned on strategy, reviewed progress, and set priorities for the upcoming cycle.
Expanding our network to bring quality products closer to more pharmacies and healthcare providers.
For interviews, press materials, or media questions, our team is here to help.
Contact Media Team